227. Walking Better with MS: The Truth About Ampyra (Dalfampridine) from a Physical Therapist

In this episode, I delve into the intricacies of Ampyra, an FDA-approved medication designed to enhance walking in individuals with multiple sclerosis (MS). Sharing insights from both research and my experience as a physical therapist specializing in MS, I discuss the medication’s impact on walking speed and quality.  Discover the importance of maintaining a strict 12-hour medication schedule and learn how Ampyra acts as a potassium channel blocker to enhance nerve conduction. I also provide real-life anecdotes from my MS clients, highlighting improvements in walking quality, reduced spasticity, and fatigue.  Join me in exploring how combining Ampyra with tailored physical therapy can maximize benefits and improve walking and balance. This episode is packed with expert advice, practical tips, and resources to empower those living with MS to enhance their mobility and quality of life. Don’t miss this informative session on navigating walking challenges with MS and discovering potential treatment options!   Resources mentioned in the episode: MSWS-12, Multiple Sclerosis Walking Scale - 12 steps: https://www.apta.org/patient-care/evidence-based-practice-resources/test-measures/12-item-multiple-sclerosis-walking-scale-msws-12   Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: [email protected]  Website: www.MSingLink.com Social:  ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink